These medications work by mimicking natural hormones that slow gastric emptying and regulate appetite, which explains why digestive symptoms are so prevalent
Important: Do not use a GLP-1 receptor agonist together with a DPP-4 inhibitor, as combining them provides no additional benefit
This kind of price for a preclinical asset is on the high end of the range for a US biotech seeking to outlicense its IND-ready asset
Without any clear rationale, the study outcome measures were purposefully modified midtrial to alter the findings in favour of their hypothesis (549, 550)
For instance, KRAS mutations in colorectal cancer serve as a negative predictor for response to anti-EGFR therapies [11], while amplification of HER2 in gastric cancer led to the approval of trastuzumab, one of the first targeted treatments in gastrointestinal (GI) oncology [12, 13]